US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tectonic Therapeutic, Inc.

18.25

+0.65003.69%

Post-market: 18.500.2500+1.37%16:54 EDT

Volume:918.55K

Turnover:16.31M

Market Cap:341.50M

PE:-4.53

High:18.88

Open:17.76

Low:16.79

Close:17.60

52wk High:61.07

52wk Low:13.70

Shares:18.71M

Float Shares:9.74M

Volume Ratio:0.89

T/O Rate:9.43%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.0289

EPS(LYR):-6.8293

ROE:-29.32%

ROA:-18.97%

PB:1.20

PE(LYR):-2.67

Loading ...

Overview Company News Filings

Tectonic Therapeutic Shares Rise in Premarket on Positive Data for XT45 Drug

Mizuho Securities Keeps Their Buy Rating on Tectonic Therapeutic (TECX)

Tectonic Therapeutic Reports Positive Phase 1b Results for TX45 in PH-HFrEF Patients

Tectonic Therapeutic Inc - Tx45 Well Tolerated With No Serious Adverse Events in Ph-Hfref

THOMSON REUTERS

Tectonic Therapeutic Inc - Tx45 Improves Heart Function and Pulmonary Hemodynamics in Ph-Hfref

THOMSON REUTERS

Tectonic Therapeutic Announces Positive Topline Data From Phase 1B Part B Clinical Trial for Tx45 in Patients With Group 2 Pulmonary Hypertension in Hfref

THOMSON REUTERS

Mizuho Securities Sticks to Their Buy Rating for Tectonic Therapeutic (TECX)

Mizuho Securities Keeps Their Buy Rating on Tectonic Therapeutic (TECX)

Tectonic Therapeutic Shares up 4.4% Premarket After Oppenheimer Initiates Coverage With Outperform Rating

THOMSON REUTERS

Oppenheimer Initiates Tectonic Therapeutic at Outperform With $80 Price Target

MT Newswires Live

Top Premarket Decliners

MT Newswires Live

Tectonic Therapeutic Inc. to Participate in Upcoming September Investor Conferences

TScan Therapeutics Appoints Leiden Dworak as Principal Accounting Officer, Jason Amello Continues as CFO

Tectonic Therapeutic Inc reports results for the quarter ended June 30 - Earnings Summary

Tectonic Therapeutic Inc expected to post a loss of $1.03 a share - Earnings Preview

Tectonic Therapeutic Inc. Added to Russell 3000® Index

Tectonic Therapeutic Q2 EPS $(1.07) Misses $(1.00) Estimate

Tectonic Therapeutic Announces Second Quarter 2025 Financial Results and Recent Business Highlights

THOMSON REUTERS

Truist Securities Initiates Coverage on Tectonic Therapeutic With Buy Rating, $64 Price Target

MT Newswires Live

Tectonic Therapeutic Files $400 Million Mixed Shelf

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TECX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TECX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TECX\",,,,,undefined,":{"symbol":"TECX","market":"US","secType":"STK","nameCN":"Tectonic Therapeutic, Inc.","latestPrice":18.25,"timestamp":1761940800000,"preClose":17.6,"halted":0,"volume":918547,"hourTrading":{"tag":"盘后","latestPrice":18.5,"preClose":18.25,"latestTime":"16:54 EDT","volume":2643,"amount":48046.000155,"timestamp":1761944045611},"delay":0,"floatShares":9741870,"shares":18712128,"eps":-4.028914,"marketStatus":"Post-Mkt","change":0.65,"latestTime":"10-31 16:57:02 EDT","open":17.76,"high":18.88,"low":16.79,"amount":16308396.905773,"amplitude":0.11875,"askPrice":18.5,"askSize":1500,"bidPrice":18,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.028914,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1761955200000},"marketStatusCode":4,"adr":0,"listingDate":1529553600000,"exchange":"NASDAQ","adjPreClose":17.6,"preHourTrading":{"tag":"盘前","latestPrice":18,"preClose":17.6,"latestTime":"09:27 EDT","volume":2841,"amount":50986.46106,"timestamp":1761917270047},"postHourTrading":{"tag":"盘后","latestPrice":18.5,"preClose":18.25,"latestTime":"16:54 EDT","volume":2643,"amount":48046.000155,"timestamp":1761944045611},"volumeRatio":0.887596,"impliedVol":1.4515,"impliedVolPercentile":0.8601},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TECX\",,,,,undefined,":{"symbol":"TECX","floatShares":9741870,"roa":"-18.97%","roe":"-29.32%","lyrEps":-6.829308,"volumeRatio":0.887596,"shares":18712128,"dividePrice":0,"high":18.88,"amplitude":0.11875,"preClose":17.6,"low":16.79,"week52Low":13.7,"pbRate":"1.20","week52High":61.07,"institutionHeld":0,"latestPrice":18.25,"committee":-0.875,"eps":-4.028914,"divideRate":0,"volume":918547,"delay":0,"ttmEps":-4.028914,"open":17.76,"prevYearClose":46.17,"prevWeekClose":17.15,"prevMonthClose":15.69,"prevQuarterClose":15.69,"fiveDayClose":17.15,"twentyDayClose":15.24,"sixtyDayClose":21.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TECX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-20","symbol":"TECX","fiscalQuarterEnding":"2024/12","expectedEps":-1.39,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"post","actualEps":-0.84},{"market":"US","date":"2024-08-14","symbol":"TECX","fiscalQuarterEnding":"2024/06","expectedEps":-1.96,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":-3.81},{"market":"US","date":"2024-06-21","symbol":"TECX","defaultRemindTime":1718976600000,"type":"split","dateTimestamp":1718942400000,"forFactor":12,"toFactor":1,"ratio":12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TECX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TECX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2222,"buy":0.7778,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7778,"analysts":9,"updateTime":1756958400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TECX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TECX","date":"2025-10-30","current":-4.368423,"percent":0.863354,"low":-15.128417,"twenty":-11.354588,"median":-6.807553,"eighty":-5.47552,"high":-4.171801,"avg":-7.876843,"sd":2.955403,"marketCap":348419823},"quantilePoints":[{"date":"2024-06-28","current":-5.572811,"twenty":-5.572811,"median":-5.572811,"eighty":-5.572811,"marketCap":242968986},{"date":"2024-07-05","current":-5.30076,"twenty":-5.567404,"median":-5.37342,"eighty":-5.30076,"marketCap":231107856},{"date":"2024-07-12","current":-5.555913,"twenty":-5.557941,"median":-5.380179,"eighty":-5.318334,"marketCap":242232270},{"date":"2024-07-15","current":-5.724889,"twenty":-5.566052,"median":-5.386938,"eighty":-5.322727,"marketCap":249599431},{"date":"2024-08-02","current":-6.005389,"twenty":-5.571459,"median":-5.412285,"eighty":-5.328134,"marketCap":261828955},{"date":"2024-08-09","current":-5.542396,"twenty":-5.687715,"median":-5.542396,"eighty":-5.354494,"marketCap":241642930},{"date":"2024-08-16","current":-5.435122,"twenty":-5.578219,"median":-5.468047,"eighty":-5.376124,"marketCap":249010092},{"date":"2024-08-23","current":-5.531661,"twenty":-5.571459,"median":-5.454529,"eighty":-5.368797,"marketCap":253433038},{"date":"2024-08-30","current":-6.110556,"twenty":-5.781665,"median":-5.503532,"eighty":-5.376124,"marketCap":279955101},{"date":"2024-09-06","current":-5.875782,"twenty":-5.972264,"median":-5.537028,"eighty":-5.386938,"marketCap":269198931},{"date":"2024-09-13","current":-5.628143,"twenty":-5.904726,"median":-5.566052,"eighty":-5.419098,"marketCap":257853382},{"date":"2024-09-20","current":-6.367842,"twenty":-5.997993,"median":-5.603857,"eighty":-5.427493,"marketCap":291742684},{"date":"2024-09-27","current":-9.191562,"twenty":-6.110556,"median":-5.628143,"eighty":-5.435122,"marketCap":421111409},{"date":"2024-10-04","current":-9.545331,"twenty":-6.174877,"median":-5.71982,"eighty":-5.437631,"marketCap":437319336},{"date":"2024-10-11","current":-9.969854,"twenty":-7.795782,"median":-5.795859,"eighty":-5.451149,"marketCap":456768849},{"date":"2024-10-18","current":-11.555382,"twenty":-9.545331,"median":-5.890254,"eighty":-5.454529,"marketCap":529409830},{"date":"2024-10-25","current":-11.706538,"twenty":-9.969854,"median":-5.972264,"eighty":-5.473714,"marketCap":536335035},{"date":"2024-10-31","current":-13.205232,"twenty":-10.302396,"median":-6.005389,"eighty":-5.479995,"marketCap":604997707},{"date":"2024-11-08","current":-14.578499,"twenty":-10.949472,"median":-6.102515,"eighty":-5.516712,"marketCap":667913933},{"date":"2024-11-15","current":-11.919174,"twenty":-11.683382,"median":-6.165229,"eighty":-5.530429,"marketCap":637413561},{"date":"2024-11-22","current":-12.383564,"twenty":-11.738699,"median":-6.271359,"eighty":-5.540249,"marketCap":662248209},{"date":"2024-11-29","current":-13.732542,"twenty":-12.061704,"median":-6.592968,"eighty":-5.550506,"marketCap":734388858},{"date":"2024-12-06","current":-14.140821,"twenty":-12.551724,"median":-9.005029,"eighty":-5.561996,"marketCap":756222838},{"date":"2024-12-13","current":-12.789085,"twenty":-12.985735,"median":-9.500306,"eighty":-5.570107,"marketCap":683934662},{"date":"2024-12-20","current":-12.154596,"twenty":-12.971537,"median":-9.744728,"eighty":-5.576867,"marketCap":650003477},{"date":"2024-12-27","current":-14.124269,"twenty":-13.152703,"median":-9.969854,"eighty":-5.599,"marketCap":755337676},{"date":"2025-01-03","current":-12.604255,"twenty":-13.140244,"median":-10.085633,"eighty":-5.628143,"marketCap":674050360},{"date":"2025-01-10","current":-12.102182,"twenty":-13.156277,"median":-10.423321,"eighty":-5.628143,"marketCap":647200466},{"date":"2025-01-17","current":-11.591832,"twenty":-13.147343,"median":-10.551179,"eighty":-5.628143,"marketCap":619907991},{"date":"2025-01-24","current":-11.641488,"twenty":-13.118945,"median":-10.789946,"eighty":-5.669309,"marketCap":622563475},{"date":"2025-01-31","current":-15.128417,"twenty":-13.118945,"median":-10.854276,"eighty":-5.707721,"marketCap":809037464},{"date":"2025-02-07","current":-11.751833,"twenty":-13.160922,"median":-11.088711,"eighty":-5.722861,"marketCap":628464551},{"date":"2025-02-14","current":-9.495261,"twenty":-13.14913,"median":-10.854276,"eighty":-5.773563,"marketCap":507787555},{"date":"2025-02-21","current":-8.506286,"twenty":-13.126045,"median":-10.619502,"eighty":-5.791808,"marketCap":454899165},{"date":"2025-02-28","current":-7.053859,"twenty":-13.096949,"median":-10.42964,"eighty":-5.830305,"marketCap":377226257},{"date":"2025-03-07","current":-6.264886,"twenty":-13.019156,"median":-10.085633,"eighty":-5.866777,"marketCap":335033567},{"date":"2025-03-14","current":-6.485578,"twenty":-12.9375,"median":-9.998798,"eighty":-5.877518,"marketCap":346835718},{"date":"2025-03-21","current":-6.118678,"twenty":-12.909913,"median":-9.812505,"eighty":-5.894306,"marketCap":327214642},{"date":"2025-03-28","current":-6.086564,"twenty":-12.89943,"median":-9.616813,"eighty":-5.925952,"marketCap":352911127},{"date":"2025-04-04","current":-5.365575,"twenty":-12.884363,"median":-9.495261,"eighty":-5.866777,"marketCap":311106742},{"date":"2025-04-11","current":-5.368793,"twenty":-12.859408,"median":-9.098295,"eighty":-5.744909,"marketCap":311293368},{"date":"2025-04-17","current":-5.652039,"twenty":-12.823844,"median":-8.754564,"eighty":-5.718806,"marketCap":327716520},{"date":"2025-04-25","current":-7.203453,"twenty":-12.768119,"median":-8.686977,"eighty":-5.718806,"marketCap":417670599},{"date":"2025-05-02","current":-6.327966,"twenty":-12.71936,"median":-7.972411,"eighty":-5.735661,"marketCap":366908131},{"date":"2025-05-09","current":-6.765709,"twenty":-12.692301,"median":-7.373862,"eighty":-5.754394,"marketCap":392289365},{"date":"2025-05-16","current":-6.581736,"twenty":-12.656097,"median":-7.149345,"eighty":-5.762118,"marketCap":386130683},{"date":"2025-05-23","current":-7.065807,"twenty":-12.564531,"median":-7.186261,"eighty":-5.770487,"marketCap":414529699},{"date":"2025-05-30","current":-7.129463,"twenty":-12.495775,"median":-7.095238,"eighty":-5.776626,"marketCap":418264201},{"date":"2025-06-06","current":-7.145377,"twenty":-12.443994,"median":-7.13742,"eighty":-5.787757,"marketCap":419197827},{"date":"2025-06-13","current":-7.142194,"twenty":-12.36315,"median":-7.186261,"eighty":-5.807341,"marketCap":419011101},{"date":"2025-06-20","current":-6.301936,"twenty":-12.281494,"median":-7.142194,"eighty":-5.853269,"marketCap":369715678},{"date":"2025-06-27","current":-6.38628,"twenty":-12.154596,"median":-7.082825,"eighty":-5.875782,"marketCap":374663893},{"date":"2025-07-03","current":-6.792087,"twenty":-12.147975,"median":-7.059833,"eighty":-5.878096,"marketCap":398471342},{"date":"2025-07-11","current":-6.913033,"twenty":-12.118896,"median":-6.973858,"eighty":-5.899516,"marketCap":405566895},{"date":"2025-07-18","current":-7.409549,"twenty":-12.104154,"median":-7.026462,"eighty":-5.933028,"marketCap":434696009},{"date":"2025-07-25","current":-7.091269,"twenty":-12.042953,"median":-7.053859,"eighty":-5.962214,"marketCap":416023500},{"date":"2025-08-01","current":-7.062624,"twenty":-11.940968,"median":-7.068109,"eighty":-5.97136,"marketCap":414342974},{"date":"2025-08-08","current":-6.203416,"twenty":-11.917716,"median":-7.065807,"eighty":-5.992847,"marketCap":409301397},{"date":"2025-08-15","current":-6.939766,"twenty":-11.877344,"median":-7.026462,"eighty":-6.0019,"marketCap":457885772},{"date":"2025-08-22","current":-7.202099,"twenty":-11.774935,"median":-6.999065,"eighty":-6.004887,"marketCap":475194490},{"date":"2025-08-29","current":-7.251729,"twenty":-11.715597,"median":-7.030845,"eighty":-6.03864,"marketCap":478469112},{"date":"2025-09-05","current":-4.897824,"twenty":-11.689171,"median":-7.003448,"eighty":-6.000923,"marketCap":323158450},{"date":"2025-09-12","current":-5.113363,"twenty":-11.65593,"median":-6.973858,"eighty":-5.925952,"marketCap":337379667},{"date":"2025-09-19","current":-4.435551,"twenty":-11.611694,"median":-6.967633,"eighty":-5.830305,"marketCap":292657681},{"date":"2025-09-26","current":-4.171801,"twenty":-11.588522,"median":-6.913033,"eighty":-5.76405,"marketCap":275255402},{"date":"2025-10-03","current":-4.324946,"twenty":-11.567755,"median":-6.886411,"eighty":-5.708978,"marketCap":285359952},{"date":"2025-10-10","current":-4.84394,"twenty":-11.47132,"median":-6.858925,"eighty":-5.628143,"marketCap":319603146},{"date":"2025-10-17","current":-5.005593,"twenty":-11.39707,"median":-6.851764,"eighty":-5.570107,"marketCap":330269059},{"date":"2025-10-24","current":-4.931857,"twenty":-11.370036,"median":-6.829161,"eighty":-5.529196,"marketCap":325403905},{"date":"2025-10-30","current":-5.280688,"twenty":-11.354588,"median":-6.807553,"eighty":-5.47552,"marketCap":348419823}],"updateTime":1761901491518},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TECX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2579149718","title":"Tectonic Therapeutic Shares Rise in Premarket on Positive Data for XT45 Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2579149718","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579149718?lang=en_us&edition=fundamental","pubTime":"2025-10-30 20:25","pubTimestamp":1761827100,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic shares jumped in premarket trading Thursday after the company reported positive trial data for its treatment of pulmonary hypertension and heart failure.Shares traded 23% higher ahead of the opening bell at $22.90.Data from the phase 1b part B acute hemodynamic clinical trial showed that a single intravenous dose of its TX45 drug was well tolerated and brought on meaningful improvements in both left heart function and pulmonary hemodynamics.TX45 is Tectonic's new drug that aims to improve heart and lung function in patients with group 2 pulmonary hypertension and heart failure. This condition involves elevated blood pressure in the lungs due to left heart disease, leading to poor heart and lung performance.Tectonic also noted that there were no serious health issues and the drug was well tolerated among the cohort of patients.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Tectonic Therapeutic Shares Rise in Premarket on Positive Data for XT45 Drug","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TECX","BK4139"],"gpt_icon":0},{"id":"2579151723","title":"Mizuho Securities Keeps Their Buy Rating on Tectonic Therapeutic (TECX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2579151723","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579151723?lang=en_us&edition=fundamental","pubTime":"2025-10-30 08:55","pubTimestamp":1761785735,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Uy Ear from Mizuho Securities reiterated a Buy rating on Tectonic Therapeutic, with a price target of $85.00. The c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-keeps-their-buy-rating-on-tectonic-therapeutic-tecx-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-keeps-their-buy-rating-on-tectonic-therapeutic-tecx-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECX","MFG"],"gpt_icon":0},{"id":"2579138473","title":"Tectonic Therapeutic Reports Positive Phase 1b Results for TX45 in PH-HFrEF Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2579138473","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579138473?lang=en_us&edition=fundamental","pubTime":"2025-10-30 04:01","pubTimestamp":1761768078,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic Inc. announced positive topline results from its Phase 1b Part B clinical trial evaluating TX45, a long-acting Fc-relaxin fusion protein, in patients with Group 2 pulmonary hypertension in heart failure with reduced ejection fraction . The trial demonstrated that a single intravenous dose of TX45 was well tolerated and showed meaningful improvements in left heart function and pulmonary hemodynamics. No serious or severe adverse events, clinically significant changes in blood pressure, or immune-related reactions were reported. The company is also conducting the APEX Phase 2 trial of TX45 in patients with Group 2 pulmonary hypertension in heart failure with preserved ejection fraction , with topline results expected in 2026. The Phase 1b results were presented by the company on October 29, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nNDL9GFJbv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00B64PRP62.GBP","NDAQ","IE00BKPKM429.USD","LU0314104364.USD","LU2095319765.USD","BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4139","IE00BGHQF748.EUR","LU2210150020.SGD","TECX","BK4588"],"gpt_icon":0},{"id":"2579139629","title":"Tectonic Therapeutic Inc - Tx45 Well Tolerated With No Serious Adverse Events in Ph-Hfref","url":"https://stock-news.laohu8.com/highlight/detail?id=2579139629","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579139629?lang=en_us&edition=fundamental","pubTime":"2025-10-30 04:01","pubTimestamp":1761768061,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nTUA9F1MB7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TECX"],"gpt_icon":0},{"id":"2579139151","title":"Tectonic Therapeutic Inc - Tx45 Improves Heart Function and Pulmonary Hemodynamics in Ph-Hfref","url":"https://stock-news.laohu8.com/highlight/detail?id=2579139151","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579139151?lang=en_us&edition=fundamental","pubTime":"2025-10-30 04:01","pubTimestamp":1761768061,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nTUA9F1MB7:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TECX","BK4139"],"gpt_icon":0},{"id":"2579138484","title":"Tectonic Therapeutic Announces Positive Topline Data From Phase 1B Part B Clinical Trial for Tx45 in Patients With Group 2 Pulmonary Hypertension in Hfref","url":"https://stock-news.laohu8.com/highlight/detail?id=2579138484","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579138484?lang=en_us&edition=fundamental","pubTime":"2025-10-30 04:01","pubTimestamp":1761768061,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nTUA9F1MB7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TECX"],"gpt_icon":0},{"id":"2577235785","title":"Mizuho Securities Sticks to Their Buy Rating for Tectonic Therapeutic (TECX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2577235785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577235785?lang=en_us&edition=fundamental","pubTime":"2025-10-22 17:35","pubTimestamp":1761125708,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Uy Ear reiterated a Buy rating on Tectonic Therapeutic today and set a price target of $85.00. The company’s shares close...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-their-buy-rating-for-tectonic-therapeutic-tecx-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-their-buy-rating-for-tectonic-therapeutic-tecx-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECX","MFG"],"gpt_icon":0},{"id":"2575231065","title":"Mizuho Securities Keeps Their Buy Rating on Tectonic Therapeutic (TECX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2575231065","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575231065?lang=en_us&edition=fundamental","pubTime":"2025-10-14 07:55","pubTimestamp":1760399706,"startTime":"0","endTime":"0","summary":"In a report released today, Uy Ear from Mizuho Securities reiterated a Buy rating on Tectonic Therapeutic, with a price target of $85.00. The compa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-keeps-their-buy-rating-on-tectonic-therapeutic-tecx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-keeps-their-buy-rating-on-tectonic-therapeutic-tecx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MFG","TECX"],"gpt_icon":0},{"id":"2564393491","title":"Tectonic Therapeutic Shares up 4.4% Premarket After Oppenheimer Initiates Coverage With Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2564393491","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564393491?lang=en_us&edition=fundamental","pubTime":"2025-09-03 20:21","pubTimestamp":1756902117,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250903:nL4N3UQ0TA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TECX"],"gpt_icon":0},{"id":"2564362622","title":"Oppenheimer Initiates Tectonic Therapeutic at Outperform With $80 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2564362622","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564362622?lang=en_us&edition=fundamental","pubTime":"2025-09-03 18:31","pubTimestamp":1756895471,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic (TECX) has an average rating of buy and mean price target of $79.75, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TECX","OPY"],"gpt_icon":0},{"id":"2564804869","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2564804869","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564804869?lang=en_us&edition=fundamental","pubTime":"2025-09-02 19:49","pubTimestamp":1756813765,"startTime":"0","endTime":"0","summary":"Globavend (GVH) shares fell 17% pre-bell Tuesday, shaving gains from the previous session.Professional Diversity Network (IPDN) stock was down 14%, paring Friday's rally.ALT5 Sigma (ALTS) shares were ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","GVH","IPDN","ALTS","BK4139","BK4077","BK4131","TECX","BK4130"],"gpt_icon":0},{"id":"2562089037","title":"Tectonic Therapeutic Inc. to Participate in Upcoming September Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2562089037","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562089037?lang=en_us&edition=fundamental","pubTime":"2025-08-28 21:00","pubTimestamp":1756386027,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic, Inc., a clinical stage biotechnology company specializing in therapeutic proteins and antibodies targeting G-protein coupled receptors, is set to participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on September 10, 2025. Alise Reicin, MD, the President and CEO, will present at the fireside chat scheduled for 3:20 PM EDT.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tectonic Therapeutic Inc. published the original content used to generate this news brief via GlobeNewswire  on August 28, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nNDL1tzTNY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","BK4588","LU2089284900.SGD","LU0006306889.USD","LU1548497426.USD","LU1720051017.SGD","LU2028103732.USD","LU2023251221.USD","LU0795875169.SGD","LU0234570918.USD","LU0971096721.USD","LU1244550494.USD","LU1074936037.SGD","IE00B3QW5Z07.USD","LU1244550221.USD","IE00B64PRP62.GBP","LU2271345857.HKD","BK4516","LU0098860793.USD","LU0267386448.USD","LU0795875086.SGD","IE00BKVL7J92.USD","LU2210150020.SGD","LU2357305700.SGD","IE00BZ1G4Q59.USD","LU1989772840.SGD","BK4112","LU1244550577.SGD","IE00BGHQF748.EUR","LU1989772923.USD","LU0106831901.USD","LU0912757837.SGD","TECX","LU2133065610.SGD","LU0225283273.USD","LU0158827948.USD","LU1363072403.SGD","BK4581","BK4139","LU2095319765.USD","BK4585","NDAQ","LU2347655156.SGD","BK4127","LU1162221912.USD","LU2210149790.SGD","LU2089283258.USD","LU1732800096.USD","LU0106261372.USD","LU0158827781.USD"],"gpt_icon":0},{"id":"2561489746","title":"TScan Therapeutics Appoints Leiden Dworak as Principal Accounting Officer, Jason Amello Continues as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2561489746","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561489746?lang=en_us&edition=fundamental","pubTime":"2025-08-21 04:11","pubTimestamp":1755720669,"startTime":"0","endTime":"0","summary":"TScan Therapeutics Inc. has announced a change in its management team. On August 14, 2025, Leiden Dworak was appointed as the company's Principal Accounting Officer. Dworak, who has been serving as Vice President of Finance since April 2022, replaces Jason A. Amello in this role. Amello will continue as the Chief Financial Officer and Principal Financial Officer. Dworak brings extensive experience from his previous roles at AVROBIO, Inc. and Moderna, Inc.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TScan Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 20, 2025,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDL96cKKH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","BK4551","BK4534","BK4532","BK4533","BK4568","BK4539","BK4139","BK4585","TCRX","BK4588","BK4548","BK4501","TECX"],"gpt_icon":0},{"id":"2558372644","title":"Tectonic Therapeutic Inc reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2558372644","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558372644?lang=en_us&edition=fundamental","pubTime":"2025-08-12 20:00","pubTimestamp":1755000000,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic Inc reports results for the quarter ended June 30 - Earnings SummaryTectonic Therapeutic Inc TECX.OQ reported a quarterly adjusted loss of $1.07 per share for the quarter ended Ju","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nL8N3U40RC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TECX"],"gpt_icon":0},{"id":"2557828526","title":"Tectonic Therapeutic Inc  expected to post a loss of $1.03 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2557828526","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557828526?lang=en_us&edition=fundamental","pubTime":"2025-08-08 19:17","pubTimestamp":1754651825,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic Inc  expected to post a loss of $1.03 a share - Earnings Preview Tectonic Therapeutic Inc TECX.OQ TECX.O is expected to  show no change in quarterly revenue when it reports  resul","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL8N3U01PI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TECX"],"gpt_icon":0},{"id":"2557594988","title":"Tectonic Therapeutic Inc. Added to Russell 3000® Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2557594988","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557594988?lang=en_us&edition=fundamental","pubTime":"2025-08-08 05:09","pubTimestamp":1754600998,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic Inc.  has been added to the Russell 3000 Index as of June 2025. This inclusion reflects the company's growing market capitalization and broadens its exposure to institutional investors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tectonic Therapeutic Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 07, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nNDL8ZKVWt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TECX","BK4139"],"gpt_icon":0},{"id":"2557990305","title":"Tectonic Therapeutic Q2 EPS $(1.07) Misses $(1.00) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557990305","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557990305?lang=en_us&edition=fundamental","pubTime":"2025-08-08 04:46","pubTimestamp":1754599619,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic Q2 EPS $(1.07) Misses $(1.00) Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46981979/tectonic-therapeutic-q2-eps-1-07-misses-1-00-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Tectonic Therapeutic Q2 EPS $(1.07) Misses $(1.00) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TECX"],"gpt_icon":0},{"id":"2557595273","title":"Tectonic Therapeutic Announces Second Quarter 2025 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2557595273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557595273?lang=en_us&edition=fundamental","pubTime":"2025-08-08 04:01","pubTimestamp":1754596860,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nTUA8NJFQG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TECX"],"gpt_icon":0},{"id":"2553247289","title":"Truist Securities Initiates Coverage on Tectonic Therapeutic With Buy Rating, $64 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2553247289","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553247289?lang=en_us&edition=fundamental","pubTime":"2025-07-21 20:57","pubTimestamp":1753102656,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic Inc (TECX) has an average rating of Buy and mean price target of $79.71, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TECX"],"gpt_icon":0},{"id":"2549209568","title":"Tectonic Therapeutic Files $400 Million Mixed Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2549209568","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549209568?lang=en_us&edition=fundamental","pubTime":"2025-07-08 05:30","pubTimestamp":1751923855,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic  filed a registration statement late Monday for a sale of $400 million of securities from time to time.The securities cover common and preferred shares, debt securities, and warrants.The company plans to use the net proceeds to advance clinical development and for general corporate purposes.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","TECX"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":29,"code":"91000000","status":"200"}]}}